Oragenics focuses on developing treatments and vaccines for viral and bacterial threats.
Active 2020–2021. The register lists this client once for every firm that files on its behalf; all 2 of its records are shown together here.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2021 | AMERICAN DEFENSE INTERNATIONAL |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination (No Activity) |
— | |
| 2021 | AMERICAN DEFENSE INTERNATIONAL |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2021 | AMERICAN DEFENSE INTERNATIONAL |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$10,000 | |
| 2021 | AMERICAN DEFENSE INTERNATIONAL |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$10,000 | |
| 2020 | AMERICAN DEFENSE INTERNATIONAL |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2020 | MILNE, WIENER & SHOFE GLOBAL STRATEGIES (FKA M&W GOVERNMENT… |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination |
$50,000 | |
| 2020 | AMERICAN DEFENSE INTERNATIONAL |
4th Quarter (Oct 1 - Dec 31) Registration |
— | |
| 2020 | MILNE, WIENER & SHOFE GLOBAL STRATEGIES (FKA M&W GOVERNMENT… |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$50,000 | |
| 2020 | MILNE, WIENER & SHOFE GLOBAL STRATEGIES (FKA M&W GOVERNMENT… |
2nd Quarter (Apr 1 - June 30) AMENDED |
$40,000 | |
| 2020 | MILNE, WIENER & SHOFE GLOBAL STRATEGIES (FKA M&W GOVERNMENT… |
2nd Quarter (Apr 1 - June 30) Registration |
— |
| Firm | Filings | Amount |
|---|---|---|
| MILNE, WIENER & SHOFE GLOBAL STRATEGIES (FKA M&W GOVER… | 4 | $140,000 |
| AMERICAN DEFENSE INTERNATIONAL | 6 | $20,000 |
| Issue | Activities |
|---|---|
| Budget/Appropriations | 3 |
| Defense | 3 |
| Health Issues | 3 |
| Medical/Disease Research/Clinical Labs | 3 |